New onset of autoimmune diseases following COVID-19 diagnosis

AE Gracia-Ramos, E Martin-Nares… - Cells, 2021 - mdpi.com
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities

P Hosseini, MS Fallahi, G Erabi, M Pakdin… - Frontiers in molecular …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), has led to huge concern worldwide. Some SARS-CoV-2 …

Distinguishing between multisystem inflammatory syndrome, associated with COVID-19 in children and the Kawasaki disease: development of preliminary criteria …

MM Kostik, LV Bregel, IS Avrusin, EA Dondurei… - Frontiers in …, 2021 - frontiersin.org
Objectives: Diagnostic between multisystem inflammatory syndrome associated with COVID-
19 in children (MIS-C) and Kawasaki disease (KD) can make difficulties due to many …

A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children

F Haslak, A Gunalp, O Kasapcopur - Current Opinion in …, 2023 - journals.lww.com
Although children are likely to have a milder COVID-19 course compared with adults, MIS-C
as a postinfectious and life-threatening complication was reported in the pediatric age. After …

Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study

NK Bagri, RK Deepak, S Meena, SK Gupta… - Rheumatology …, 2022 - Springer
To study the clinical, laboratory characteristics and outcomes of multisystem inflammatory
syndrome in children (MIS-C) temporally related to coronavirus disease 2019 (COVID-19) in …

Diagnosis of multisystem inflammatory syndrome in children by a whole-blood transcriptional signature

HR Jackson, L Miglietta… - Journal of the …, 2023 - academic.oup.com
Background To identify a diagnostic blood transcriptomic signature that distinguishes
multisystem inflammatory syndrome in children (MIS-C) from Kawasaki disease (KD) …

Who would have predicted multisystem inflammatory syndrome in children?

DD Reiff, RQ Cron - Current Rheumatology Reports, 2022 - Springer
Abstract Purpose of Review Multisystem inflammatory disease in children (MIS-C) is a novel
post-infectious phenomenon following coronavirus disease-19 (COVID-19). Herein, we …

Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort

E Rey-Jurado, Y Espinosa, C Astudillo… - Journal of Allergy and …, 2022 - Elsevier
Background Multisystemic inflammatory syndrome in children (MIS-C) is a life-threatening
disease that occurs 2-5 weeks after severe acute respiratory syndrome coronavirus 2 …

Multisystem inflammatory syndrome in children: clinical presentation, management, and short-and long-term outcomes

M Sezer, E Çelikel, ZE Tekin, F Aydın, T Kurt… - Clinical …, 2022 - Springer
Objective In this study, it was aimed to evaluate the demographic, clinical and laboratory
characteristics of MIS-C patients in our hospital, to share our treatment approach, and to …

Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome

P Buda, E Strauss… - Frontiers in …, 2022 - frontiersin.org
Background Macrophage activation syndrome (MAS) is a potentially life-threatening
complication of various inflammatory disorders, including multisystem inflammatory …